Holen Sie sich die Stockscreener-App
2.37
2.07%
-0.05
Matinas Biopharma Holdings Inc Aktie (MTNB) Neueste Nachrichten
Stock splits calendar for: - Yahoo Finance Australia
Matinas BioPharma Holdings, Inc.: Dividend historical data and projections - marketscreener.com
MTNB Q4 2024 Earnings: Narrower-Than-Expected Loss Meets Negative Stock ReactionProfit Inflection Point - https://www.dars.gov.et/
Stock splits calendar for: - Yahoo Finance Australia
Matinas BioPharma Holdings, Inc. Revenue Breakdown – GETTEX:6LJ - TradingView
Enterprise value to revenue forward of Matinas BioPharma Holdings, Inc. – FWB:6LJ - TradingView
Book value per share of Matinas BioPharma Holdings, Inc. – MUN:6LJ - TradingView
Form DEF 14A Matinas BioPharma Holdings Inc For: 29 September By Investing.com - Investing.com Canada
Form DEF 14A Matinas BioPharma Holdings Inc For: 29 September By Investing.com - Investing.com UK
Stock splits calendar for: - Yahoo Finance Singapore
Stock splits calendar for: - Yahoo Finance Singapore
Matinas BioPharma (MTNB) Climbs 8.4% as Sub-$1 Biotech Pushes Toward $0.18 ResistanceInitial Balance - siam.in
Matinas BioPharma (MTNB) Climbs 8.4% as Sub-$1 Biotech Pushes Toward $0.18 ResistancePre-Earnings Momentum - dars.gov.et
Matinas BioPharma announces one-for-fifteen reverse stock split approval By Investing.com - Investing.com India
Matinas BioPharma announces one-for-fifteen reverse stock split approval - Investing.com
Matinas BioPharma announces one-for-fifteen reverse stock split approval By Investing.com - Investing.com Australia
Form 8K Matinas BioPharma Holdings Inc For: 16 September By Investing.com - Investing.com Nigeria
Matinas BioPharma announces one-for-fifteen reverse stock split approval By Investing.com - Investing.com Canada
Form 8K Matinas BioPharma Holdings Inc For: 16 September By Investing.com - Investing.com Canada
Matinas BioPharma to implement 1-for-15 reverse stock split effective Sept. 28, 2026 - TradingView
Form 8K Matinas BioPharma Holdings Inc For: 16 September By Investing.com - Investing.com UK
A first commercial hydrogen deal covers up to 1,000 kilograms a day from GH Power’s facility. - Stock Titan
Price to sales forward of Matinas Biopharma Holdings, Inc. – BOATS:MTNB - TradingView
Matinas BioPharma Share PriceMTNB, RNS News, Articles, Quotes, & Charts (OTCMKTS:MTNB) - Proactive financial news
Matinas Biopharma (MTNB) Holds Steady at $0.18 as Key Support HoldsDark Pool Prints - careplusvn.com
Matinas BioPharma Receives New NYSE American Delisting Risk on Equity Shortfall - minichart.com.sg
Matinas BioPharma Faces NYSE American Compliance Challenges - TipRanks
Matinas BioPharma Receives NYSE American Noncompliance Notice for Continued Listing Standards - Quiver Quantitative
Matinas BioPharma Received Notice of Noncompliance - tradingview.com
Matinas BioPharma Receives Notice of Non-Compliance with NYSE American Continued Listing Standards - GlobeNewswire
symbol__ Stock Quote Price and Forecast - CNN
Matinas BioPharma Receives Notice of Non-Compliance with NYSE American Continued Listing Standards - Yahoo Finance
Matinas (MTNB) Results Review: EPS Lands Above Forecast in the Latest Reading; Closing Move: Shares Finish 1.16% Down at the ClosePerformance Review - vinanet.vn
Hydrogen startup GH Power lines up deal with Matinas BioPharma (NYSE: MTNB) - stocktitan.net
Matinas (MTNB) Session: Finishes 1.16% Down at $0.20 on the Day; Levels: the Near-Term Reference Band Stretches From $0.19 to $0.21 in the Current UpdateWave Equality - vinanet.vn
Matinas (MTNB) Q4 2024 Earnings: EPS Beats Its Estimate at the Close; Market Response: Shares Move 8.93% Higher in the Latest ReadingShare Repurchase Impact - vinanet.vn
Matinas (MTNB) Q4 2024 Earnings: EPS Beats Its Estimate at the Close; Market Response: Shares Move 8.93% Higher in the Latest ReadingWeak Earnings Momentum - vinanet.vn
Matinas (MTNB) Q4 2024 Earnings: EPS Beats Its Estimate at the Close; Market Response: Shares Move 8.93% Higher in the Latest ReadingProduct Revenue Analysis - vinanet.vn
Matinas (MTNB) Q4 2024 Earnings: EPS Beats Its Estimate at the Close; Market Response: Shares Move 8.93% Higher in the Latest ReadingEarnings Outlook Update - careplusvn.com
Matinas (MTNB) Q4 2024 Earnings: EPS Beats Its Estimate at the Close; Market Response: Shares Move 8.93% Higher in the Latest ReadingBuyback Announcement Report - careplusvn.com
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
Top Premarket Decliners - marketscreener.com
Matinas (MTNB) Results Review: The Bottom-Line Figure Outpaces Its Comparison for the Current Session; Market Response: The Stock Loses 8.33%Earnings Trend Analysis - vinanet.vn
Matinas Biopharma Holdings Inc. (MTNB) Q4 2024 Earnings: Narrower Loss of -$0.82 Beats Estimates as Clinical Pipeline AdvancesRevenue Warning Signal - vinanet.vn
Matinas Biopharma Holdings Inc. (MTNB) Q4 2024 Earnings: Narrower Loss of -$0.82 Beats Estimates as Clinical Pipeline AdvancesRevenue Surprise History - dars.gov.et
Matinas Biopharma Holdings Inc. (MTNB) Q4 2024 Earnings: Narrower Loss of -$0.82 Beats Estimates as Clinical Pipeline AdvancesReturn On Equity - dars.gov.et
Matinas BioPharma (MTNB) holder Adam Stern details 9.99% stake and new warrants - Stock Titan
Matinas Biopharma (MTNB) Slips 2.6% to $0.26 as Micro-Cap Biotech Tests SupportBreakout Stock Alerts - careplusvn.com
Matinas Biopharma (MTNB) Slips 2.6% to $0.26 as Micro-Cap Biotech Tests SupportZero Gamma Level - vinanet.vn
US Micro Cap StocksInvest from India - INDmoney
4.22%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):